Completed PHASE1 INTERVENTIONAL 2-arm NCT06072716

The Anti-fungal Effect of Miconazol Versus Miconazol-Loaded Chitosan Nanoparticles

The Anti-fungal Effect of Miconazol and Miconazol-Loaded Chitosan Nanoparticles in Diabetic Patients With Oral Candidiasis-Randomized Control Clinical Trial and Microbiological Analysis

Sponsor: Yasmine gamil

Conditions Oral Thrush

Interventions Chitosan

Updated 3 times since 2023 Last updated: Oct 3, 2023 Started: Jan 10, 2023 Primary completion: Jul 27, 2023 Completion: Jul 27, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06072716, this PHASE1 trial focuses on Oral Thrush and remains completed. Sponsored by Yasmine gamil, it has been updated 3 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Nov 2023 — Jul 2024 [monthly]

Completed PHASE1

First recorded

Jan 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yasmine gamil

Data source: MTI University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Giza, Egypt